1. Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia
   Francesco Scolari et al, 2022, Frontiers in Immunology CrossRef
2. Comparative pharmacoeconomic analysis of rituximab and traditional tacrolimus regimens in membranous nephropathy in China
   Li Zeng et al, 2024, Frontiers in Pharmacology CrossRef
3. Tacrolimus Protects Podocytes from Apoptosis via Downregulation of TRPC6 in Diabetic Nephropathy
   Ruixia Ma et al, 2021, Journal of Diabetes Research CrossRef
4. Evaluating Efficacy and Safety of Tacrolimus Treatment in Membranous Nephropathy: Results of a Retrospective Study of 182 Patients
   Shuang Liang et al, 2023, Therapeutics and Clinical Risk Management CrossRef
5. Effects of tacrolimus on proteinuria in Chinese and Indian patients with idiopathic membranous nephropathy: the results of machine learning study
   Min Rui et al, 2024, International Urology and Nephrology CrossRef
6. Clinicopathological features and prognosis in patients with idiopathic membranous nephropathy with hypertension
   Wanjun Lu et al, 2020, Experimental and Therapeutic Medicine CrossRef
7. Efficacy of tacrolimus monotherapy in primary membranous nephropathy
   Ya-pu Zhang et al, 2024, Open Medicine CrossRef
8. Anti-phospholipase A2 receptor-associated membranous nephropathy with human immunodeficiency virus infection treated with telitacicept: A case report
   Jin-Ling Wang et al, 2023, World Journal of Clinical Cases CrossRef